Lingkang Pharmaceutical: Cancellation of 8,915,900 shares

Lingkang Pharmaceutical announced that 8.9159 million shares repurchased in the special securities account will be cancelled on April 22, 2026. After the cancellation of the shares, the company's total share capital will change from 721 million shares to 712 million shares, and the company's registered capital will change from 721 million yuan to 712 million yuan.